4-O-(4,4-dimethyl-2-oxopyrrolidin-3-yl) 1-O-(2-methylpropanoyloxymethyl) (E)-but-2-enedioate
C15H21NO7 — CID 122482420
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-O-(4,4-dimethyl-2-oxopyrrolidin-3-yl) 1-O-(2-methylpropanoyloxymethyl) (E)-but-2-enedioate
4-O-(4,4-dimethyl-2-oxopyrrolidin-3-yl) 1-O-(2-methylpropanoyloxymethyl) (E)-but-2-enedioate (PubChem CID 122482420) has the molecular formula C15H21NO7 and a molecular weight of 327.33 g/mol. Its IUPAC name is 4-O-(4,4-dimethyl-2-oxopyrrolidin-3-yl) 1-O-(2-methylpropanoyloxymethyl) (E)-but-2-enedioate.
Molecular Properties
| Compound Name | 4-O-(4,4-dimethyl-2-oxopyrrolidin-3-yl) 1-O-(2-methylpropanoyloxymethyl) (E)-but-2-enedioate |
|---|---|
| PubChem CID | 122482420 |
| Molecular Formula | C15H21NO7 |
| Molecular Weight | 327.33 g/mol |
| Exact Mass | 327.13 |
| IUPAC Name | 4-O-(4,4-dimethyl-2-oxopyrrolidin-3-yl) 1-O-(2-methylpropanoyloxymethyl) (E)-but-2-enedioate |
| SMILES | CC(C)C(=O)OCOC(=O)/C=C/C(=O)OC1C(=O)NCC1(C)C |
| InChI | InChI=1S/C15H21NO7/c1-9(2)14(20)22-8-21-10(17)5-6-11(18)23-12-13(19)16-7-15(12,3)4/h5-6,9,12H,7-8H2,1-4H3,(H,16,19)/b6-5+ |
| InChIKey | DIHMBQGGYCYZFL-AATRIKPKSA-N |
| XLogP | 0.31 |
| TPSA | 108.00 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 327.33 |
| LogP ≤ 5 | 0.31 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122482420 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.